131 related articles for article (PubMed ID: 37461496)
1. Cannabis use is associated with pain severity and interference among cancer survivors.
Nugent SM; Latour E; Lim J; Shannon J; Morasco BJ
Res Sq; 2023 Jul; ():. PubMed ID: 37461496
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, reasons for use, perceived benefits, and awareness of health risks of cannabis use among cancer survivors - implications for policy and interventions.
Osaghae I; Chido-Amajuoyi OG; Talluri R; Shete S
J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38158514
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access.
McClure EA; Walters KJ; Tomko RL; Dahne J; Hill EG; McRae-Clark AL
Support Care Cancer; 2023 Jun; 31(7):429. PubMed ID: 37382737
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use after a cancer diagnosis in a population-based sample of cancer survivors.
Ton M; Newcomb PA; Jones S; Malen RC; Heffner JL
Cancer Causes Control; 2024 Mar; ():. PubMed ID: 38519643
[TBL] [Abstract][Full Text] [Related]
5. Cannabis in Cancer Survivors Who Report High Impact Chronic Pain: Findings from a 1500+ Patient Survey.
Philpot LM; Ramar P; Jatoi A; Rosedahl J; Canning R; Ebbert JO
Am J Hosp Palliat Care; 2023 Nov; 40(11):1196-1204. PubMed ID: 36469631
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional survey of the prevalence and patterns of using cannabis as a sleep aid in Canadian cancer survivors.
Lee RM; Donnan J; Harris N; Garland SN
J Cancer Surviv; 2023 Oct; ():. PubMed ID: 37837502
[TBL] [Abstract][Full Text] [Related]
7. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ
J Pain; 2020; 21(5-6):570-581. PubMed ID: 31560957
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample.
Do EK; Ksinan AJ; Kim SJ; Del Fabbro EG; Fuemmeler BF
Cancer; 2021 Nov; 127(21):4040-4049. PubMed ID: 34387864
[TBL] [Abstract][Full Text] [Related]
9. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
[No Abstract] [Full Text] [Related]
10. Preliminary assessment of medical cannabis consumption by cancer survivors.
Zolotov Y; Eshet L; Morag O
Complement Ther Med; 2021 Jan; 56():102592. PubMed ID: 33197667
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
12. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors.
Calcaterra SL; Burnett-Hartman AN; Powers JD; Corley DA; McMullen CM; Pawloski PA; Feigelson HS
BMC Cancer; 2020 May; 20(1):373. PubMed ID: 32362277
[TBL] [Abstract][Full Text] [Related]
13. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use among recently treated cancer patients: perceptions and experiences.
Salz T; Meza AM; Chino F; Mao JJ; Raghunathan NJ; Jinna S; Brens J; Furberg H; Korenstein D
Support Care Cancer; 2023 Aug; 31(9):545. PubMed ID: 37650961
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of cannabis use for medicinal reasons - An Australian cross-sectional study.
Leung J; Lim CCW; Chiu V; Chung J; Mekonen T; Dawson D; Hall WD; Chan GCK
Addict Behav Rep; 2022 Jun; 15():100436. PubMed ID: 35662918
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
[No Abstract] [Full Text] [Related]
17. Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with Cancer.
Brasky TM; Newton AM; Conroy S; Adib A; Adley NC; Strassels SA; Hays JL; Cooper ZD; Wagener TL; Stevens E; Plascak JJ; Krok-Schoen JL
Cancer Res Commun; 2023 Sep; 3(9):1917-1926. PubMed ID: 37772996
[TBL] [Abstract][Full Text] [Related]
18. Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey.
Sinclair J; Smith CA; Abbott J; Chalmers KJ; Pate DW; Armour M
J Obstet Gynaecol Can; 2020 Mar; 42(3):256-261. PubMed ID: 31722852
[TBL] [Abstract][Full Text] [Related]
19. Awareness and interest in cannabis use for cancer management among cancer survivors.
Osaghae I; Talluri R; Chido-Amajuoyi OG; Tanco K; Shah DP; Pande M; Shete S
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38180296
[TBL] [Abstract][Full Text] [Related]
20. Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies.
Blake EA; Ross M; Ihenacho U; Figueroa L; Silverstein E; Flink D; Mendez-Ishizaki Y; Yessaian A; Brunette LL; Matsuo K; Cortessis VK; Guntupalli S; Roman L
Gynecol Oncol Rep; 2019 Nov; 30():100497. PubMed ID: 31692541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
